−£226k
vs Dec 2023ActiveNI618099Private limited companyBelfast
3N DIAGNOSTICS LIMITED
Significant control: Partha Ray (25–50%), Roberto Fagnani (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does 3n Diagnostics Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
3N DIAGNOSTICS LIMITED is an active private limited company (company number NI618099) incorporated on 26 April 2013, registered in Belfast. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2024, showing net assets of −£226k and cash of £2,600, with 2 employees on average. Net assets fell 27% on the prior period (−£178k).
Peer position · net assets
By net assets it sits in the bottom quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
02
Ownership and control
- Mr Partha Ray
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr Roberto Fagnani
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 26 April 201313 yrs ago
- Next accounts due
- 30 September 202623 days overdue
- Confirmation statement due
- 10 May 2027in 199 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£2,600
+23%vs Dec 2023Not reported
2
No changevs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | −£226k | £2,600 | £1,456 | — | — | — | 2 |
| 31 December 2023 | −£178k | £2,109 | £19k | — | — | — | 2 |
Cash per employee£1,300Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-225,992 at 31 December 2024
- Net assets down 25% or more on the prior period-26.9% vs prior period
- Incorporated five or more years agoIncorporated 26 April 2013
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 199 days
- Next accounts due23 days overdue
- Accounts period endNet liabilities £226k · small accounts
- Accounts period endNet liabilities £178k · small accounts
- Incorporated
08
Similar companies in Belfast
- GENSAF LIMITEDBelfast · inc. Mar 2013
- PROAXSIS LTDAntrim · inc. Aug 2013
- FMN CLINICAL RESEARCH SERVICES LTDNewry · inc. Apr 2012
- LUCY ANNABELLA LTDDungannon · inc. May 2011
- RE-VANA THERAPEUTICS LTDBelfast · inc. May 2016
- NORLIN GENALICE LIMITEDBelfast · inc. Nov 2016
All companies incorporated on 26 April 2013 · in Apr 2013.
09
Reminders for 3N DIAGNOSTICS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.